(Q43957391)

English

Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Peter Wahlqvist

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Ola Junghard

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Andy Higgins

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Jonathan Green

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

267-277

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in the management of gastro-oesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of functional gastrointestinal disorders on quality of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological Management of Gastro-Oesophageal Reflux Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The medical management of gastro-oesophageal reflux

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term management of gastroesophageal reflux disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dyspepsia: a dilemma for doctors?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evidence-based appraisal of reflux disease management--the Genval Workshop Report

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical treatment of gastro-oesophageal reflux disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term prescribing of proton pump inhibitors in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acid-reflux disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Markov models in medical decision making: a practical guide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. The Nordic GORD Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of patient satisfaction with a formulary switch from omeprazole to lansoprazole in gastroesophageal reflux disease maintenance therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The illness behavior of patients with gastroesophageal reflux disease with and without endoscopic esophagitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and humanistic outcomes in patients with gastroesophageal reflux disease converted from omeprazole to lansoprazole.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heartburn, oesophagitis and Barrett's oesophagus in self-medicating patients in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of treatment for gastro-oesophageal reflux disease in clinical practice: a clinical database analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of gastroesophageal reflux disease on health-related quality of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950383

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200220040-00005

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43957391&oldid=2206357393"